abstract |
Liquid pharmaceutical compositions have been described that provide improved oral bioavailability for compounds that are inhibitors of HIV proteases. In particular, the composition of the present invention comprises a solution in a pharmaceutically acceptable organic solvent of (a) an HIV protease inhibitor and optionally (b) a surfactant. The compositions of the present invention may optionally be encapsulated in hard gelatin capsules or soft elastic capsules (SEC). |